Compare IRBT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRBT | OSUR |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.5M | 177.2M |
| IPO Year | N/A | 1986 |
| Metric | IRBT | OSUR |
|---|---|---|
| Price | $4.27 | $2.51 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 38.6M | 851.7K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $546,997,000.00 | $125,703,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $69.39 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.40 | $2.08 |
| 52 Week High | $13.06 | $4.22 |
| Indicator | IRBT | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 49.89 |
| Support Level | $3.04 | $2.42 |
| Resistance Level | $4.95 | $2.65 |
| Average True Range (ATR) | 0.82 | 0.12 |
| MACD | 0.37 | 0.04 |
| Stochastic Oscillator | 67.61 | 61.64 |
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.